SOURCE: MedSpas of America, Inc.

August 15, 2007 10:00 ET

Medspas of America Signs Exclusive Agreement for Natural Renu

Worldwide Rights for Natural Renu

ATLANTA, GA--(Marketwire - August 15, 2007) - Medspas of America Inc. (PINKSHEETS: MEDP),, announced today that it has signed an exclusive worldwide agreement with Zymetech from Reykjavick, Iceland,, for the exclusive use of Penzim as the essential ingredient in the anti-aging line of products for Natural Renu.

Zymetech owns the worldwide patents for an active ingredient called Penzyme derived from enzymes produced by fish, particularly cod in the North Atlantic. This enzyme has been clinically tested for the treatment of pain, inflammation, arthritis, bursitis, eczema, psoriasis, fybromyalgia, eczema, acne and other skin conditions, such as itching, dry skin and brown spots.

"Our agreement with Zymetech provides Natural Renu with a unique selling position in the $5.4 billion cosmeceutical industry. This exclusive new line of products fits with our forward-looking vision of offering unique services and products to our clients through the internet and our own Medspas," states Paul Smith, CEO of Medspas of America.

About Natural Renu

The new division will operate under the brand name of Natural Renu. The company will focus its sales efforts primarily through two marketing channels. The first and primary sales channel shall be the Internet. By utilizing its existing skill set and marketing prowess in this area, the company shall initiate an intensive online awareness campaign and drive potential users of this type of product to its web site. The second target audience shall be to exclusive Dayspas, Resorts and Medspas around the world.

SAFE HARBOR STATEMENT: Except for historical information contained herein, the statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition and risk inherent in the operations of a company.

Contact Information

  • Investor Contact Information:

    Rich Kaiser
    Investor Relations